Emilio Abara

Providers must use JZ modifier to attest zero drug waste from single-dose vials.

Infusion practices need specialized RCM vetting criteria to avoid revenue leaks.

Missing data in infusion claims triggers provider liability, not patient bills.

CMS requires coders to use XU instead of modifier 59 for distinct infusion services.

Medicare now covers remote supervision of infusion centers via video.

Billing infrastructure for new infusions can't keep pace with market growth.

Silent margin drains in buy-and-bill contracting cost practices thousands monthly.

Infusion billing contracts often hide gaps in drug-cost coverage until denials pile up.

Infusion billing stacks complexity that demands specialty-specific revenue cycle discipline.

Payers shift drug costs to pharmacies to capture rebates and pricing leverage.